Assessment of morphological changes in internal organs in the treatment of Aleutian mink disease with Alloferon
https://doi.org/10.52419/issn2072-2419.2021.4.41
Abstract
Nowdays, viral plasmocytosis of mink is widespread all over the world, due to the lack of effective treatments. A key role in the outcome of the disease is often played by kidney damage associated with the development of glomerulonephritis as a result of hypergammaglobulinemia. It is for this reason that the problem of finding a remedy for the treatment and prevention of Aleutian mink disease becomes urgent. The studies were carried out on mink of the sapphire breed at the age of 30 to 40 days in patients with viral plasmocytosis, confirmed by molecular genetic analysis. The experimental and control groups consisted of 20 animals each. The minks of the experimental group were injected subcutaneously twice with an interval of 6 days with alloferon at a dose of 0.5 mg per head, and the minks of the control group were injected with saline solution (NaCl 0.9%) in the same volume and multiplicity. During the study, records of fallen minks were kept. At the end of the experiment, histological studies of internal organs were carried out. The conducted experience showed that the use of alloferon led to a reduction in mortality, as well as a several-fold decrease in the intensity of plasmocytic infiltration of organs and tissues in experimental minks.
About the Authors
A. A. SukhininRussian Federation
Dr. Habil. (Biol. Sci.), professor
M. M. Gumberidze
Russian Federation
Postgraduate student
V. I. Gusev
Russian Federation
leading specialist in advanced research
I. V. Evsegneeva
Russian Federation
Development Director
B. A. Nikonov
Russian Federation
leading specialist
G. P. Becker
Russian Federation
General Director
References
1. Инфекционные болезни животных: учеб. пособие / Б. Ф. Бессарабов, А. А. Вашутин, Е. С. Воронин [и др.]. — М.: Колос, 2007. — 671 с
2. Патент № 2 172 322 РФ, МПК C 07 K 7/06, 7/08, A 61 K 38/08, 38/10, A 61 P 37/02 Черныш С.И., Ким Су Ин., Беккер Г.П., Махалдиани Н.Б., Хоффманн Ж., Бюле Ф. Аллофероны-иммуномодулирующие пептиды; заявитель и патентообладатель Энтофарм Ко., Лтд. №99127725/04; заявл. 27.12.1999; опубл. 20.08.2001;
3. Тирикова, О.В. Гломерулонефриты: учеб. пособие / О.В. Тирикова, И.А. Филатова: под ред. Н. М. Козловой. ФГБОУ ВО ИГМУ Минздрава России, Кафедра факультетской терапии. – Иркутск: ИГМУ, 2017. – 44с.
4. Хронический гломерулонефрит: клиника, диагностика, лечение на амбулатор ном этапе: учеб. пособие / С.М. Лобанова, М.С. Булгаков, А.Г. Автандилов, Н.А. Михайлова; ФГБОУ ДПО «Российская медицинская академия непрерывного профессионального образования». – М.: ФГБОУ ДПО РМАНПО, 2016. – 38 с.
5. Сухинин, А.А. Лабораторная диагностика вирусных болезней: учеб. пособие / А.А. Сухинин. –Санкт-Петербург: 2019. -124с.
6. The effect of alloferon on the enhancement of NK cell cytotoxicity against cancer via the up-regulation of perforin/granzyme B secretion. / S. Bae, K. Oh, H. Kim [et al] // Immunobiology. - 2013. - Vol. 218(8). - P. 1026-33.
7. Antibody-dependent cell cytotoxicity: immunotherapy strategies enhancing effector NK cells / MC Ochoa, L. Minute, I. Rodriguez, [et al] // Immunol Cell Biol. - 2017. - Vol. 95(4). – P. 347-355.
Review
For citations:
Sukhinin A.A., Gumberidze M.M., Gusev V.I., Evsegneeva I.V., Nikonov B.A., Becker G.P. Assessment of morphological changes in internal organs in the treatment of Aleutian mink disease with Alloferon. International Journal of Veterinary Medicine. 2021;(4):41-45. (In Russ.) https://doi.org/10.52419/issn2072-2419.2021.4.41